85-2053-05　［取扱停止］MIM1 (4-(E)-[[(2Z)-2-cyclohexylimino)-4-m ethyl-1,3-thiazol-3(2H)-yl]imino]methyl]benzene-1, 2,3-triol) 50mg　167681

特徴

• Solubility:100mM in DMSO and 20mM in ethanol
• Molecular Formula:C17H21N3O3S
• Biological Activity:Inhibitor of Mcl-1; selectively targets the BH3-binding pocket. Induces caspase-3/7 activation and cell death in Mcl-1-dependent leukemia cells. Also blocks Mcl-1-mediated suppression of tBID-induced Bax activation in vitro.
• Storage and Stability:Lyophilized powder may be stored at -20°C. Stable for 12 months at -20°C. Reconstitute with sterile buffer or ddH2O. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Reconstituted product is stable for 6 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.

仕様

• Size：50mg
• Grade：Purified
• Form：Supplied as a solid.
• Molecular Formula：C17H21N3O3S
• Molecular Weight Non Ab：347.43
• EU Commodity Code：38220090
• この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
• 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。

• 【試薬に関するお問合せ】
• アズワン株式会社 試薬・プロセス材料グループ
• TEL：06-6447-8641
• FAX：06-6447-8642
• E-mail：[email protected]